N. O. Demirci

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis

M. Kamasak, S. Saip, A. Siva, 2012, Multiple sclerosis.

AB0308 THE ASSOCIATION OF PARKINSON DISEASE WITH RHEUMATOID ARTHRITIS

N. O. Demirci, S. Arda, F. Coşan, 2019, Abstracts Accepted for Publication.

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes

O. U. Sezerman, U. Uygunoğlu, S. Saip, 2015, PloS one.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls?

S. Saip, A. Siva, O. Uysal, 2012, European Radiology.

A patient with established primary progressive multiple sclerosis transitions to ‘secondary’ relapsing–remitting disease course following a fulminant demyelinating episode

O. Kantarci, S. Saip, A. Siva, 2011, Multiple sclerosis.